Osteogenic and chondrogenic potential of biomembrane cells from the PMMA-segmental defect rat model

Journal of Orthopaedic Research

Volumn 30, Issue 8, 2012, Pages 1198-1212

  Gruber, Helen E ^a   Riley, Frank E ^a   Hoelscher, Gretchen L ^a   Bayoumi, Essraa M ^a   Ingram, Jane A ^a   Ramp, Warren K ^b   Bosse, Michael J ^a   Kellam, James F ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b Health Research Group   (United States)

Author keywords

biomembrane; chondrogenesis; osteogenesis; stem cell differentiation; tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL MARKER; CHONDROITIN SULFATE; FRIZZLED PROTEIN; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MALE; MEMBRANE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PERIOSTEUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CHONDROGENESIS; FRACTURE HEALING; MALE; MESENCHYMAL STEM CELLS; MODELS, ANIMAL; OSTEOGENESIS; POLYMETHYL METHACRYLATE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TISSUE ENGINEERING;

EID: 84862775136     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22047     Document Type: Article

References (147)

1. Giannoudis PV, Faour O, Goff T, et al. 2011. Masquelet technique for the treatment of bone defects: tips-tricks and future directions. Injury 42: 591-598.
2. Pelissier P, Martin D, Baudet J, et al. 2002. Behaviour of cancellous bone graft placed in induced membranes. Br J Plast Surg 55: 596-598.
3. Masquelet AC,. 2003. Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction. Langenbecks Arch Surg 388: 344-346.
4. Viateau V, Guillemin G, Calando Y, et al. 2005. Reconstruction de perte de substance osseuse massive par la procédure de Masquelet: modèle expérimental chez la brebis. J Bone Joint Surg Br 90B: 254.
5. Al-Muaid J, Franciolli M, Klaue K,. 2007. Tubular remodeling of massive cancellous bone graft in the treatment of long bone defects. Eur J Trauma Emerg Surg 33: 654-658.
6. Masquelet AC, Fitoussi F, Begue T, et al. 2000. Reconstruction des os longs par membrane induite et autogreffe spongieuse. Ann Chir Plast Esthét 45: 346-353.
7. Masquelet AC, Begue T,. 2010. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin N Am 41: 27-37.
8. Ristiniemi J, Lakovaara M, Flinkkilã T, et al. 2007. Staged method using antibiotic beads and subsequent autografting for large traumatic tibial bone loss. 22 or 23 fractures healed after 5-20 months. Acta Orthop 78: 520-527.
9. Pelissier P, Masquelet AC, Bareille R, et al. 2004. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 22: 73-79.
10. Viateau V, Guillemin G, Calando Y, et al. 2006. Induction of a barrier membrane to facilitate reconstruction of massive segmental diaphyseal bone defects: an ovine model. Vet Surg 35: 445-452.
11. Gettys FK, Gruber HE, Kellam JF, et al. 2011. Cellular origin and gene expression patterns of methacrylate induced biomembranes in a rat femur. 63rd Annual Meeting. Assoc Bone Joint Surg; abstract.
12. Montijo HE, Gettys FF, Starman JS, et al. 2011. A novel rat femur defect model using the AO rat nail. Orthopaedic Trauma Association 2011 program: abstract #576.
13. Choi Y-S, Noh S-E, Lim S-M, et al. 2008. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 30: 593-601.
14. De Bari C, Dell'Accio F, Vanlauwe J, et al. 2006. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54: 1209-1221.
15. Dominici M, LeBlanc K, Mueller E, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
16. Tapp H, Deepe R, Ingram JA, et al. 2008. Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type 1 rich extracellular matrix. Arthritis Res Ther 10: R89.
17. Gruber HE, Deepe R, Hoelscher GL, et al. 2010. Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells. Tissue Eng Part A 16: 2843-2860.
18. Pittenger MF, Mackay AM, Beck SC, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
19. Callis GM,. 2008. In, Bancroft JD, Gamble M, editors. Theory and practice of histological techniques. 6th ed. Philadelphia: Elsevier; 333-363.
20. Viateau V, Guillemin G, Bousson V, et al. 2007. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res 25: 741-749.
21. Becerra J, Santos-Ruiz L, Andrades JA, et al. 2011. The stem cell niche should be a key issue for cell therapy in regenerative medicine. Stem Cell Rev Rep 7: 248-255.
22. Yagi H, Soto-Gutiérrez A, Parekkadan BKY, et al. 2010. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19: 667-679.
23. Bianco P,. 2011. The stem cell next door: skeletal and hematopoietic stem cell "niches" in bone. Endocrinology 152: 2957-2962.
24. Chamberlain G, Fox J, Ashton B, et al. 2007. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749.
25. Caplan AI,. 2009. New era of cell-based orthopedic therapies. Tissue Eng Part B 15: 195-200.
26. Aubin JE, Zhang S, Uchida S,. 2003. Mesenchymal stem cells and their progeny: developmental paradigms governing osteoblast differentiation & bone formation. Eur Cell Mater 5: 1.
27. Aubin JE,. 2008. Mesenchymal stem cells and osteoblast-chondroblast differentiation. Eur Cell Mater 16: 1.
28. Aubin JE, Triffitt JT,. 2002. Mesenchymal stem cells and osteoblast differentiation. In, Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology, 2nd ed. London, UK: Academic Press; 59-81.
29. Guilak F, Estes BT, Dickman BO, et al. 2010. 2010 Nicolas Andry Award: multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering. Clin Orthop Relat Res 468: 2530-2540.
30. Itoh S, Aubin JE,. 2009. A novel purification method for multipotential skeletal stem cells. J Cell Biochem 108: 368-377.
31. Ducy P, Starbuck M, Priemel M, et al. 1997. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13: 1025-1036.
32. Si Y-L, Zhao Y-L, Hao H-J, et al. 2011. MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev 10: 93-103.
33. de Peppo GM, Sjovall P, Lennerås M, et al. 2010. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A 16: 3413-3426.
34. Heino TJ, Hentunen TA,. 2008. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther 3: 131-145.
35. Salgado AS, Oliveira JT, Pedro AJ, et al. 2006. Adult stem cells in bone and cartilage tissue engineering. Curr Stem Cell Res Ther 1: 345-364.
36. Griggin M, Iqbal SA, Bayat A,. 2011. Exploring the application of mesenchymal stem cells in bone repair and regeneration. J Bone Joint Surg Br 93B: 427-434.
37. Barry FP, Murphy JM,. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36: 568-584.
38. Zou XH, Cai HX, Chen X, et al. 2009. A novel strategy incorporated the power of mesenchymal stem cells to allografts for segmental bone tissue engineering. Cell Transplant 18: 433-441.
39. Kimelman-Bleich N, Pelled G, Zilberman Y, et al. 2011. Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol Ther 19: 53-59.
40. Peters A, Toben D, Lienau J, et al. 2009. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. Tissue Eng Part A 15: 2947-2954.
41. Kemmis CM, Vahdati A, Weiss HE, et al. 2010. Bone morphogenetic protein 6 drives both osteogenesis and chondrogenesis in murine adipose-derived mesenchymal cells depending on culture conditions. Biochem Biophys Res Commun 401: 20-25.
42. Grasser WA, Orlic I, Borovecki F, et al. 2007. BMP-6 exerts its osteoinductive effect through activation of IGF-1 and EGF pathways. Int Orthop 31: 759-765.
43. Ducy P, Karsenty G,. 1997. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15: 1858-1869.
44. Ducy P, Zhang R, Geoffroy V, et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
45. Delhon I, Gutzwiller S, Morvan F, et al. 2009. Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density. Endocrinology 150: 4463-4472.
46. Rajalin AM, Pollock H, Aarnisalo P,. 2010. ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells. Biochem Biophys Res Commun 396: 477-482.
47. Severe N, Miraoui H, Marie PJ,. 2011. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbi-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination. J Biol Chem 286: 24443-24450.
48. Xiao L, Naganawa T, Obugunde E, et al. 2004. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279: 27743-27752.
49. Haupt LM, Murali S, Mun FK, et al. 2009. The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1cells toward osteogenesis. J Cell Physiol 220: 780-791.
50. Cool SM, Grunert M, Jackson R, et al. 2005. Role of growth hormone receptor signaling in osteogenesis from murine bone marrow progenitor cells. Biochem Biophys Res Commun 338: 1048-1058.
51. Miyakoshi N, Richman C, Kasukawa Y, et al. 2001. Evidence the IGF-binding protein-5 functions as a growth factor. J Clin Invest 107: 73-81.
52. Pereira CT, Huang W, Jarrahy R, et al. 2009. Human and mouse osteoprogenitor cells exhibit distinct patterns of osteogenesis in three-dimensional tissue engineering scaffolds. Plast Reconstr Surg 124: 1869-1879.
53. Fujii T, Komatsu Y, Yasoda A, et al. 2010. Circulating C-type natriuretic peptide (CNP) rescues chondroplastic CNP knockout mice from their impaired skeletal growth and early death. Endocrinology 151: 4381-4388.
54. Ninomiya K, Miyamoto T, Imai J, et al. 2007. Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem Biophys Res Commun 362: 460-466.
55. Nakade O, Baylink DJ, Lau KH,. 1996. Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1. J Bone Miner Res 11: 1880-1888.
56. Bassett JH, Nordström K, Boyde A, et al. 2007. Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol 21: 1893-1904.
57. Verrier S, Hogan A, McKie N, et al. 2004. ADAM gene expression and regulation during human osteoclast formation. Bone 35: 34-46.
58. Moser M, Binder O, Wu T, et al. 2003. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol 23: 5664-5679.
59. Tang N, Song W-S, Luo J, et al. 2009. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin siganlling. J Cell Mol Med 13: 2448-2464.
60. Morko J, Kiviranta R, Mulari MT, et al. 2009. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro. Bone 44: 717-728.
61. Watanabe T, Kukita T, Kukita A, et al. 2004. Direct stimulation of osteoclastogenesis by MIP-1 alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180: 193-201.
62. Scheven BA, Milne JS, Hunter I, et al. 2011. Macrophage-inflammatory protein-1alpha regulates preosteoclast differentiation in vitro. Biochem Biophys Res Commun 254: 773-778.
63. Abboud SL, Ghosh-Choudhury N, Liu LC, et al. 2003. Osteoblast-specific targeting of soluble colony-stimulating factor-1 increases cortical bone thickness in mice. J Bone Miner Res 18: 1386-1394.
64. Dai XM, Zong XH, Akhter MP, et al. 2004. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res 19: 1441-1451.
65. Chaudhary LR, Cheng SL, Avoili LV,. 1996. Induction of early growth response-1 gene by interleukin-1 beta and tumor necrosis factor-alpha in normal human bone marrow stromal and osteoblastic cells: regulation by a protein kinase C inhibitor. Mol Cell Biochem 156: 69-77.
66. Leclerc N, Noh T, Cogan J, et al. 2008. Opposing effects of glucocorticoids and Wnt signaling on Drox20 and mineral deposition in osteoblast cultures. J Cell Biochem 103: 1938-1951.
67. Asian H, Zilberman Y, Kandel L, et al. 2006. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24: 1728-1737.
68. Mongiat M, Fu J, Oldershaw R, et al. 2003. Perlecan protein core interacts with extracellular matrix protein (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 278: 17491-17499.
69. Nakahara T, Sato H, Shimizu T, et al. 2010. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells. Biochem Biophys Res Commun 394: 243-248.
70. Nistala H, Lee-Artega S, Smaldone S, et al. 2010. Fibrilin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol 190: 1107-1121.
71. Yerges LM, Zhang Y, Cauley JA, et al. 2009. Functional characterization of genetic variation in the frizzled 1 (FZD1) propoter and associateion with bone phenotypes: more to the LRP5 story? J Bone Miner Res 24: 87-96.
72. Abdelmagid SM, Barbe MF, Arango-Hisijara I, et al. 2007. Osteoactivin acts as a downstream mediator of BMP-2 effects on osteoblast function. J Cell Physiol 210: 26-37.
73. Mikhail BD, Steinstraesser L,. 2010. Regulation of human adipose-derived stromal cell osteogenic differentiation by insulin-like growth factor-1 and platelet-derived growth factgor-alpha. Plast Reconstr Surg 126: 41-52.
74. Koch H, Jadlowiec JA, Campbell PG,. 2005. Insulin-like growth factor-1 induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14: 621-631.
75. Zhou P, Kitaura H, Teitelbaum SL, et al. 2006. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cycline and p27. J Immunol 177: 8777-8784.
76. Liu CJ, Chang E, Yu J, et al. 2005. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation. J Biol Chem 280: 2788-2796.
77. Hoebertz K, Bell A, Keon N, et al. 2004. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164: 613-623.
78. Liedert A, Mattausch L, Rontgen V, et al. 2011. Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading. Bone 48: 945-951.
79. Lawton DM, Andrew JG, Marsh DR, et al. 1999. Expression of the gene encoding the matrix gla protein by mature osteoblasts in human fracture non-unions. Mol Pathol 52: 92-96.
80. Inoue Y, Hendy GN, Canaff L, et al. 2011. Menin interacts with beta-catenin in osteoblast differentiation. Horm Metab Res 43: 183-187.
81. Engin F, Lee B,. 2010. Notching the bone: insights into multi-functionality. Bone 46: 274-280.
82. Liu Y, Hair GA, Boden SD, et al. 2002. Overexpressed LIM mineralization proteins do not require LIM domains to induce bone. J Bone Miner Res 17: 406-414.
83. Nuka S, Sawada N, Iba K, et al. 1997. All-trans retinoic acid inhibits dexamethasone-induced ALP activity and mineralization in human osteoblastic cell line SV HFO. Cell Struct Funct 22: 27-32.
84. Bodine PV, Zhao W, Kharode YP, et al. 2004. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of travecular bone formation in adult mice. Mol Endocrinol 18: 1222-1237.
85. Oshima T, Abe M, Asano J, et al. 2005. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 106: 3160-3165.
86. Shen B, Wei A, Whittaker S, et al. 2010. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem 109: 406-416.
87. Blumer MJ, Longato S, Fritsch H,. 2008. Localizatin of tartrate-resistant acid phosphatase (TRAP), membrane type-1 matrix metalloproteinases (MT1-MMP) and macrophages during early endochondral bone formation. J Anat 213: 431-441.
88. Kaunitz JD, Yamaguchi DT,. 2008. TNAP, TrAP, ecto-purinergic signaling, and bone remodeling. J Cell Biochem 105: 655-662.
89. Wang J, Stern PH,. 2010. Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Galpha(12) or constitutively active RhoA. J Cell Biochem 111: 1531-1536.
90. Boxkey AL, Paschalis EP, Binderman I, et al. 2002. BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures. J Cell Biochem 84: 509-519.
91. Bridgewater LC, Lefebvre V, De Crombrugghe B,. 1998. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1. J Biol Chem 273: 14998-15006.
92. Bonnelye E, Zirngibl RA, Jurdic P, et al. 2007. The orphan nuclear estrogen receptor-related receptor-alpha regulates cartilage formation in vitro: implication of Sox9. Endocinrology 148: 1195-1205.
93. Dailey L, Laplantine E, Prior R, et al. 2003. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161: 1053-1066.
94. Gevers EF, van der Eerden BC, Karperien M, et al. 2002. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res 17: 1408-1419.
95. Kim HJ, Im GI,. 2009. Combination of transforming growth factor-beta2 and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 15: 1543-1551.
96. Wang L, Shao YY, Ballock RT,. 2011. Leptin synergizes with thyroid hormone signaling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone 48: 1022-1027.
97. Huang BL, Brugger SM, Lyons KM,. 2010. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin. J Biol Chem 285: 27702-27712.
98. Ivkovic S, Yoon BS, Popoff SN, et al. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130: 2779-2791.
99. Stelzer C, Brimmer A, Hermanns P, et al. 2007. Expression profile of Papss2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo. Dev Dyn 236: 1313-1318.
100. Wong M, Kireeva ML, Kolesnikova TV, et al. 1997. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol 192: 492-508.
101. Maruyama T, Mirando AJ, Deng CX, et al. 2010. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 3: ra40.
102. Nakamura Y, Weidinger G, Liang JO, et al. 2007. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J Clin Invest 117: 2075-3086.
103. Newman B, Gigout L, Sudre L, et al. 2001. Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival. J Cell Biol 154: 659-666.
104. Julien M, Magne D, Masson M, et al. 2007. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinol 148: 530-537.
105. Bobick BE, Kulyk WM,. 2008. Regulation of cartilage formation and maturation by mitogen-activated protein kinase signaling. Birth Defects Res C Embryo Today 84: 131-154.
106. Wu W, Mwale F, Tchetina E, et al. 2001. Cartilage matrix resorption in skeletogenesis. Novartis Found Symp 232: 158-166.
107. Kafienah W, Misty S, Perry MJ, et al. 2007. Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells 25: 2460-2468.
108. Morello R, Bertin TK, Schlaubitz S, et al. 2008. Brachy-syndactyly caused by loss of Sfrp2 function. J Cell Physiol 217: 127-137.
109. Huang AH, Stein A, Mauck RL,. 2010. Evaluation of the complex transcriptional topography of mesenchymal stem cell chondrogenesis for cartilage tissue engineering. Tissue Eng Part A 16: 2699-2708.
110. Ahmed N, Drier R, Gopferich A, et al. 2007. Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells. Cell Physiol Biochem 20: 665-678.
111. Davidson D, Blanc A, Filion D, et al. 2005. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280: 20509-20515.
112. Jacob AL, Smith C, Partanen J, et al. 2006. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296: 315-328.
113. Langer JC, Henckaerts E, Orenstein J, et al. 2004. Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J Exp Med 199: 5-14.
114. Le Grand F, Jones AE, Seale V, et al. 2009. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of stellite stem cells. Cell Stem Cell 4: 535-547.
115. Kim JH, Lee MC, Seong SC, et al. 2011. Enhanced proliferation and chondrogenic differentiation of human synovium-derived stem cells expanded with basic fibroblast growth factor. Tissue Eng Part A 17: 991-1002.
116. Ma DK, Ponnusamy K, Song MR, et al. 2009. Molecular genetic analysis of FGFR1 signalling reveals distinct roled of MAPK and PLCgamma1 activation for self-renewal of adult neural stem cells. Mol Brain 2: 16.
117. Lu X, Su N, Yang J, et al. 2009. Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway. Biochem Biophys Res Commun 390: 494-499.
118. Yeremenko N, Baeten D,. 2011. IL-17 in spondyloarthritis: is the T-party over? Arthritis Res Ther 13: 115.
119. Bendall SC, Stewart MH, Menendez P, et al. 2007. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448: 1015-1021.
120. Piwko-Czuchra A, Koegel H, Meyer H, et al. 2009. Beta1 integrin-mediated adhesion signalling is essential for epidermal progenitor cell expansion. PLoS ONE 5: e5488 Epub 2009 May 8.
121. Mareddy S, Dhaliwal N, Crawford R, et al. 2010. Stem cell-related gene expression in clonal populations of mesenchymal stromal cells from bone marrow. Tissue Eng Part A 16: 749-758.
122. Murayama M, Okamoto R, Tsuchiya K, et al. 2009. Musashi-1 suppresses expression of Paneth cell-specific genes in human intestinal epithelial cells. J Gastroenterol 44: 173-182.
123. Gaur T, Wixted JJ, Hussain S, et al. 2009. Secreted frizzled related protein 1 is a tartet to improve fracture healing. J Cell Physiol 220: 174-181.
124. Nakajima H, Ito M, Morikawa Y, et al. 2009. Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells. Biochem Biophys Res Commun 390: 65-70.
125. Miclea RL, Van der Horst G, Robanus-Maandag EC, et al. 2011. Apc bridges Wnt/β-catenin and BMP signaling during osteoblast differentiation of KS483 cells. Exp Cell Res 317: 1411-1421.
126. He XC, Zhang J, Li L,. 2005. Cellular and molecular regulation of hematopoietic and intestinal stem cell behavior. Ann N Y Acad Sci 1049: 28-38.
127. Zhang J, Niu C, Ye L, et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836-841.
128. Laino G, d'Aquino R, Graziano A, et al. 2005. A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB). J Bone Miner Res 20: 1394-1402.
129. Iizuka S, Kudo Y, Yoshida M, et al. 2011. Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta 1 and CD63. Mol Cell Biol 31: 783-792.
130. Kiel MJ, Morrison SJ,. 2008. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8: 290-301.
131. Gaur T, Hussain S, Mudhasani R, et al. 2010. Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse. Dev Biol 340: 10-21.
132. Kapinas K, Kessler C, Ricks T, et al. 2010. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285: 25221-25231.
133. Hamidouche Z, Hay P, Charbord P, et al. 2008. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression. FASEB 22: 3813-3822.
134. Kulterer B, Friedl G, Jandrositz A, et al. 2007. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion of osteoblast differentiation. BMC Genomics 8: 70.
135. Segev O, Samach A, Faerman A, et al. 2004. CMF608-a- A novel mechanical strain-induced bone specific protein expressed in early osteochondroprogenitor cells. Bone 34: 246-260.
136. Kesper DA, Didt-Koziel L, Vortkamp A,. 2010. Gli2 activator function in preosteoblasts is sufficient to mediate Ihh-dependent osteoblast differentiation, whereas the repressor function of Gli2 is dispensable for endochondral ossification. Dev Dyn 239: 1818-1826.
137. Keselowsky BG, Wang L, Schwartz Z, et al. 2007. Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A 80: 700-710.
138. Li L, Jothi R, Cui K, et al. 2010. Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells. Nat Immunol 12: 129-136.
139. Katsumoto T, Aikawa Y, Iwama A, et al. 2006. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev 20: 1321-1330.
140. Zhang M, Xie R, Hou W, et al. 2009. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phorphorylation, ubiquitylation and proteasomal degradation. J Cell Sci 122: 1382-1389.
141. Li TF, Dong Y, Ionescu AM, et al. 2004. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res 299: 128-136.
142. Wu Q, Ma Q, Shehadeh LA, et al. 2010. Expression of the argonaute protein Piwl2 and piRNAs in adult mouse mesenchymal stem cells. Biochem Biophys Res Commun 396: 915-920.
143. Corbell D, Joester A, Fargeas CA, et al. 2009. Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia 57: 860-874.
144. Bhattaram P, Penzo-Mendez A, Sock E, et al. 2010. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun 1: 9.
145. Hagan JP, Piskounova E, Gregory RI,. 2009. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 16: 1021-1025.
146. Wu C, Qiu R, Wang J, et al. 2009. ZHX2 interacts with ephrin-B and regulates neural progenitor maintenance in the developing cerebral cortex. J Neurosci 29: 7404-7412.
147. Canalis E, Zanotti S, Beamer WG, et al. 2010. Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Endocrinology 151: 3490-3501.